Anastasios Dimou

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Topics

Respiratory Syndrome Coronavirus

Prognostic Factors

Childhood Cancer

Top Venues

Cancer research communications

JCO precision oncology

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Yiqing Zhao, Anastasios Dimou, Zachary C Fogarty, Jun Jiang, Hongfang Liu, William Bruce Wong, Chen Wang
Real-world Trends, Rural-urban Differences, and Socioeconomic Disparities in Utilization of Narrow versus Broad Next-generation Sequencing Panels. Cancer research communications 4 (2) (2024)
Yiqing Zhao, Anastasios Dimou, Zachary C Fogarty, Jun Jiang, Hongfang Liu, William Bruce Wong, Chen Wang
Real-World Trends, Rural-Urban Differences and Socioeconomic Disparities in Utilization of Narrow vs. Broad Next-Generation Sequencing Panels. Cancer research communications (2024)
Yiqing Zhao, Anastasios Dimou, Zachary C Fogarty, Jun Jiang, Hongfang Liu, William Bruce Wong, Chen Wang
Real-World Trends, Rural-Urban Differences and Socioeconomic Disparities in Utilization of Narrow vs. Broad Next-Generation Sequencing Panels. Cancer research communications (2024)
Yiqing Zhao, Anastasios Dimou, Zachary C Fogarty, Jun Jiang, Hongfang Liu, William Bruce Wong, Chen Wang
Real-world Trends, Rural-urban Differences, and Socioeconomic Disparities in Utilization of Narrow versus Broad Next-generation Sequencing Panels. Cancer research communications 4 (2) (2024)
Tina J Hieken, Garth D Nelson, Thomas J Flotte, Eric P Grewal, Jun Chen, Robert R McWilliams, Lisa A Kottschade, Lu Yang, Evidio Domingo-Musibay, Roxana S Dronca, Yiyi Yan, Svetomir N Markovic, Anastasios Dimou, Heather N Montane, Courtney L Erskine, Mara A Piltin, Daniel L Price, Samir S Khariwala, Jane Yuet Ching Hui, Carrie A Strand, Susan M Harrington, Vera J Suman, Haidong Dong, Matthew S Block
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial. Nature communications 15 (1) (2024)
Yiqing Zhao, Anastasios Dimou, Zachary C Fogarty, Jun Jiang, Hongfang Liu, William Bruce Wong, Chen Wang
Real-world Trends, Rural-urban Differences, and Socioeconomic Disparities in Utilization of Narrow versus Broad Next-generation Sequencing Panels. Cancer research communications 4 (2) (2024)
Tina J Hieken, Garth D Nelson, Thomas J Flotte, Eric P Grewal, Jun Chen, Robert R McWilliams, Lisa A Kottschade, Lu Yang, Evidio Domingo-Musibay, Roxana S Dronca, Yiyi Yan, Svetomir N Markovic, Anastasios Dimou, Heather N Montane, Courtney L Erskine, Mara A Piltin, Daniel L Price, Samir S Khariwala, Jane Yuet Ching Hui, Carrie A Strand, Susan M Harrington, Vera J Suman, Haidong Dong, Matthew S Block
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial. Nature communications 15 (1) (2024)
Yiqing Zhao, Anastasios Dimou, Zachary C Fogarty, Jun Jiang, Hongfang Liu, William Bruce Wong, Chen Wang
Real-World Trends, Rural-Urban Differences and Socioeconomic Disparities in Utilization of Narrow vs. Broad Next-Generation Sequencing Panels. Cancer research communications (2024)
Anastasios Dimou
Time to Think About Human Leukocyte Antigen-Based Diagnostics in Lung Cancer? Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Misako Nagasaka, Yuichiro Ohe, Caicun Zhou, Chang-Min Choi, Nong Yang, Geoffrey Liu, Enriqueta Felip Font, Maurice Pérol, Benjamin Besse, Jorge J Nieva, Luis E Raez, Nathan A Pennell, Anastasios Dimou, Filippo de Marinis, Fortunato Ciardiello, Takashi Seto, Zheyi Hu, Max Pan, Weiqing Wang, Shuanglian Li, Sai-Hong Ignatius Ou
TRUST-II: a global phase II study of taletrectinib in ROS1 -positive non-small-cell lung cancer and other solid tumors. Future oncology (London, England) (2023)
Anastasios Dimou
Areas of Uncertainty in SARS-CoV-2 Vaccination for Cancer Patients. Vaccines 10 (12) (2022)
Anastasios Dimou
Areas of Uncertainty in SARS-CoV-2 Vaccination for Cancer Patients. Vaccines 10 (12) (2022)
Anastasios Dimou
Areas of Uncertainty in SARS-CoV-2 Vaccination for Cancer Patients. Vaccines 10 (12) (2022)
Anastasios Dimou, Ying-Chun Lo, Kenneth W Merrell, Kevin C Halling, Aaron S Mansfield
Small Cell Transformation in a Patient With RET Fusion-Positive Lung Adenocarcinoma on Pralsetinib. JCO precision oncology 6 (2022)
Anastasios Dimou
Areas of Uncertainty in SARS-CoV-2 Vaccination for Cancer Patients. Vaccines 10 (12) (2022)
Anastasios Dimou, Ying-Chun Lo, Kenneth W Merrell, Kevin C Halling, Aaron S Mansfield
Small Cell Transformation in a Patient With RET Fusion-Positive Lung Adenocarcinoma on Pralsetinib. JCO precision oncology 6 (2022)
Katherine B Winfree, Cliff Molife, Patrick M Peterson, Yongmei Chen, Carla M Visseren-Grul, Mark S Leusch, Julie Beyrer, Anastasios Dimou
Real-world characteristics and outcomes of advanced non-small-cell lung cancer patients with EGFR exon 19 deletions or exon 21 mutations. Future oncology (London, England) 17 (22) (2021)
Anastasios Dimou, Gregory Barron, Daniel T Merrick, Jason Kolfenbach, Robert C Doebele
Granulomatosis with polyangiitis in a patient treated with dabrafenib and trametinib for BRAF V600E positive lung adenocarcinoma. BMC cancer 20 (1) (2020)